Literature DB >> 22879115

Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.

Ya-Ting Chang1, Chiung-Chih Chang, Hung-Sheng Lin, Chi-Wei Huang, Wen-Neng Chang, Chun-Chung Lui, Chen-Chang Lee, Yu-Ting Lin, Chang-Hung Chen, Nai-Ching Chen.   

Abstract

PURPOSE: Use Taiwanese version of the Montreal Cognitive Assessment (MoCA) in evaluating patients in different stages of Alzheimer's disease (AD) and correlate with white matter change.
METHODS: Ninety-seven normal controls (NC), 52 very-mild AD (clinical dementia rating [CDR] = 0.5), 48 mild AD (CDR = 1) and 38 moderate AD (CDR = 2) patients were enrolled for the MoCA, Mini- Mental State Examination (MMSE) and the Cognitive Assessment Screening Instrument (CASI). White matter hyperintensities (WMHs) on brain MRI were visually rated and classified as deep or periventricular WMHs.
RESULTS: In NC group, education (β = 0.326) but not age (β = -0.183, p = 0.069), was significantly related to MoCA score. However, while we added two points to the AD patients with less than 6 years education, the effects of education disappeared as compared with those of 7 years of education. For all educational levels, the cutoff value of MoCA for very-mild AD was 22/23 (sensitivity = 82.7%, specificity = 87.6%). No significant differences were found in the areas under the curves that differentiated NC from the patients with AD for MoCA and MMSE (differences = 0.008, p = 0.490), or for MoCA and CASI (differences = 0.023, p = 0.082). Total WMHs, frontal deep and periventricular WMHs were inversely correlated with the attention and delayed-recall subdomain.
CONCLUSION: The MoCA is a good clinical tool for screening very-mild stage AD if the educational effects are carefully considered. The correlation between the executive subdomains with the frontal WMHs also makes it a useful tool for detecting subtle WMHs.

Entities:  

Mesh:

Year:  2012        PMID: 22879115

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  10 in total

1.  Genetic effect of MTHFR C677T polymorphism on the structural covariance network and white-matter integrity in Alzheimer's disease.

Authors:  Yu-Tzu Chang; Shih-Wei Hsu; Shih-Jen Tsai; Ya-Ting Chang; Chi-Wei Huang; Mu-En Liu; Nai-Ching Chen; Wen-Neng Chang; Jung-Lung Hsu; Chen-Chang Lee; Chiung-Chih Chang
Journal:  Hum Brain Mapp       Date:  2017-03-25       Impact factor: 5.038

Review 2.  Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias.

Authors:  Daniel H J Davis; Sam T Creavin; Jennifer L Y Yip; Anna H Noel-Storr; Carol Brayne; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

3.  Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer's disease.

Authors:  Chi-Wei Huang; Shih-Wei Hsu; Shih-Jen Tsai; Nai-Ching Chen; Mu-En Liu; Chen-Chang Lee; Shu-Hua Huang; Weng-Neng Chang; Ya-Ting Chang; Wan-Chen Tsai; Chiung-Chih Chang
Journal:  J Neuroinflammation       Date:  2017-01-18       Impact factor: 8.322

4.  The Relationship between Psychosocial Factors and Cognition in Multiple Sclerosis.

Authors:  Fahad D Alosaimi; Alaa AlMulhem; Mario Moscovici; Hanan AlShalan; Mohammad Alqazlan; Abdulgader Aldaif; Sanjeev Sockalingam
Journal:  Behav Neurol       Date:  2017-05-06       Impact factor: 3.342

5.  Diagnosis of Alzheimer's Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.

Authors:  Miguel A Chávez-Fumagalli; Pallavi Shrivastava; Jorge A Aguilar-Pineda; Rita Nieto-Montesinos; Gonzalo Davila Del-Carpio; Antero Peralta-Mestas; Claudia Caracela-Zeballos; Guillermo Valdez-Lazo; Victor Fernandez-Macedo; Alejandro Pino-Figueroa; Karin J Vera-Lopez; Christian L Lino Cardenas
Journal:  J Alzheimers Dis Rep       Date:  2021-01-11

Review 6.  Developing guidelines for the translation and cultural adaptation of the Montreal Cognitive Assessment: scoping review and qualitative synthesis.

Authors:  Ghazn Khan; Nadine Mirza; Waquas Waheed
Journal:  BJPsych Open       Date:  2022-01-07

7.  Validation of the Taiwanese Version of ACE-III (T-ACE-III) to Detect Dementia in a Memory Clinic.

Authors:  Ruan-Ching Yu; Naaheed Mukadam; Narinder Kapur; Joshua Stott; Chaur-Jong Hu; Chien-Tai Hong; Cheng-Chang Yang; Lung Chan; Li-Kai Huang; Gill Livingston
Journal:  Arch Clin Neuropsychol       Date:  2022-02-22       Impact factor: 3.448

8.  Montreal Cognitive Assessment for the detection of dementia.

Authors:  Daniel Hj Davis; Samuel T Creavin; Jennifer Ly Yip; Anna H Noel-Storr; Carol Brayne; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2021-07-13

9.  Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study.

Authors:  Jung-Lung Hsu; Yen-Chun Fan; Ya-Li Huang; Jui Wang; Wei-Hung Chen; Hou-Chang Chiu; Chyi-Huey Bai
Journal:  Alzheimers Res Ther       Date:  2015-11-09       Impact factor: 6.982

10.  Effects of Homocysteine on white matter diffusion parameters in Alzheimer's disease.

Authors:  Chen-Chang Lee; Shih-Wei Hsu; Chi-Wei Huang; Wen-Neng Chang; Sz-Fan Chen; Ming-Kung Wu; Chiung-Chih Chang; Lain-Chyr Hwang; Po-Chou Chen
Journal:  BMC Neurol       Date:  2017-10-06       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.